Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Go back to Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
(NASDAQ: CADL) Delayed: 10.36 +0.57 (5.82%)
Previous Close $9.79    52 Week High
Open $9.88    52 Week Low
Day High $10.38    P/E N/A 
Day Low $9.80    EPS
Volume 1,481,738